切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (12) : 893 -897. doi: 10.3877/cma.j.issn.1674-0785.2019.12.003

所属专题: 文献

临床研究

高危小卒中/短暂性脑缺血发作患者血压变异性与早期神经功能恶化的相关性
段作伟1,(), 杨明1, 郑艳宇1, 陶丽红1, 陈斌1   
  1. 1. 225001 扬州大学附属医院神经内科
  • 收稿日期:2019-04-12 出版日期:2019-06-15
  • 通信作者: 段作伟
  • 基金资助:
    江苏省卫计委强卫工程(QNRC2016353)

Blood pressure variability and early neurological deterioration in high-risk patients with acute minor stroke or transient ischemic attack

Zuowei Duan1,(), Ming Yang1, Yanyu Zheng1, Lihong Tao1, Bin Chen1   

  1. 1. Department of Neurology, the Affiliated Hospital of Yangzhou University, Yangzhou 225000, China
  • Received:2019-04-12 Published:2019-06-15
  • Corresponding author: Zuowei Duan
  • About author:
    Corresponding author: Duan Zuowei, Email:
引用本文:

段作伟, 杨明, 郑艳宇, 陶丽红, 陈斌. 高危小卒中/短暂性脑缺血发作患者血压变异性与早期神经功能恶化的相关性[J]. 中华临床医师杂志(电子版), 2019, 13(12): 893-897.

Zuowei Duan, Ming Yang, Yanyu Zheng, Lihong Tao, Bin Chen. Blood pressure variability and early neurological deterioration in high-risk patients with acute minor stroke or transient ischemic attack[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(12): 893-897.

目的

探讨高危小卒中/TIA患者血压变异性(BPV)与早期神经功能恶化(END)的相关性。

方法

连续前瞻性选择2017年5月至2019年5月期间在扬州大学附属医院神经内科住院治疗的急性高危小卒中/TIA患者。根据住院72 h内美国国立卫生院卒中量表(NIHSS)评分的动态变化,将患者分为END组和非END组。对2组患者各项BPV参数进行分析和比较,主要包括收缩压(SBP)和舒张压(DBP)的平均值(mean)、最大值(max)、极差(max-min)、标准差(SD)、变异系数(CV)。探讨不同BPV参数与高危小卒中/TIA患者早期END的关系。

结果

共纳入符合入组/排除标准的患者102例,男性58例,女性44例,平均年龄(62.87±12.00岁)。住院72 h内,有27(26.5%)例患者发生END。单因素分析表明,END组患者和非END组患者间年龄、性别、白细胞、C反应蛋白、SBPmax-min、SBPSD、SBPCV、DBPmax-min、DBPSD、DBPCV的差异均具有统计学意义(P均<0.05)。校正单因素分析中P<0.1的变量(包括年龄、性别、白细胞、C反应蛋白),Logistics回归分析表明,血压变异指标中的SBPmax-min[1.026(1.002~1.050)],SBPSD[1.124(1.006~1.256)],SBPCV[1.277(1.068~1.526)],DBPmax-min[1.084(1.021~1.151)],DBPSD[1.560(1.166~2.088)],DBPCV[1.439(1.154~1.793)]是高危小卒中/TIA患者入院72 h内发生END的独立危险因素。

结论

较高的血压变异性可能会增加高危小卒中/TIA患者END的发生风险。

Objective

To analyze the relationship between blood pressure (BP) variability (BPV) and early neurological deterioration (END) in high-risk patients with acute minor stroke or transient ischemic attack.

Methods

Patients with acute minor stroke or transient ischemic attack were consecutively recruited at the Affiliated Hospital of Yangzhou University between May 2017 and May 2019 and divided into two groups according to the presence of END or not. During the first 72 hours, the parameters of BPV such as BPmax, BPmax-min, BPSD, and BPCV were calculated.

Results

A total of 102 patients were recruited in this study, of whom 27 (26.5%) developed END. Univariate analysis indicated that age, sex, white blood cell count, C reactive protein, and BPV parameters such as SBPmax-min, SBPSD, SBPCV, DBPmax-min, DBPSD, and DBPCV were significantly associated with the development of END (P<0.05). After adjusting the parameters with a P-value< 0.1, logistic regression analysis demonstrated that SBPmax-min (1.026 [1.002-1.050]), SBPSD (1.124 [1.006-1.256]), SBPCV (1.277 [1.068-1.526]), DBPmax-min (1.084 [1.021-1.151]), DBPSD (1.560 [1.166-2.088]), and DBPCV (1.439 [1.154-1.793]) were all independently associated with the development of END in high-risk patients with acute minor stroke or transient ischemic attack.

Conclusion

Our study indicated that higher in-hospital BPV may increase the risk of END in high-risk patients with acute minor stroke or transient ischemic attack.

表1 2组急性高风险小卒中/TIA患者的一般临床特征比较
临床特征 END组(27例) 非END组(75例) 统计值 P
年龄(岁,±s 67.63±12.46 61.16±11.43 t=2.463 0.016
女性[例(%)] 17(63.0) 27(36.0) χ2=5.884 0.015
高血压[例(%)] 19(70.4) 45(60.0) χ2=0.913 0.339
糖尿病[例(%)] 12(44.4) 25(33.3) χ2=1.060 0.303
高脂血症[例(%)] 8(29.6) 24(32.0) χ2=0.052 0.820
冠心病[例(%)] 10(37.0) 17(22.7) χ2=2.106 0.147
吸烟[例(%)] 8(29.6) 28(37.3) χ2=0.516 0.473
饮酒[例(%)] 8(29.6) 16(21.3) χ2=0.759 0.384
基线NIHSS[MQR)] 2(1~2) 1(0~2) Z=-0.606 0.545
白细胞(×109±s 8.18±2.84 7.05±1.90 t=2.323 0.022
红细胞(×1012±s 4.49±0.54 4.41±0.57 t=0.684 0.495
空腹血糖(mmol/l,±s 6.76±2.66 6.62±2.96 t=0.224 0.823
C反应蛋白(mg/l,±s 18.36±13.09 9.79±13.96 t=2.780 0.007
治疗方式[例(%)] ? ? χ2=2.687 0.261
? 常规药物 25(92.6) 72(96.0) ? ?
? 静脉溶栓 1(3.7) 3(4.0) ? ?
? 动脉取栓 1(3.7) 0 ? ?
SBP ? ? ? ?
? SBPmean 139.26±13.32 142.90±9.73 t=-1.507 0.135
? SBPmax 182.44±24.70 172.66±28.10 t=1.599 0.113
SBPmax-min 76.15±23.10 62.31±21.10 t=2.850 0.005
? SBPSD 17.20±4.27 14.17±4.77 t=2.903 0.005
? SBPCV 12.46±2.90 10.05±2.94 t=3.668 0.000
DBP ? ? ? ?
? DBPmean 79.79±5.91 80.78±4.09 t=-0.948 0.346
? DBPmax 98.59±7.50 94.88±8.93 t=1.928 0.057
DBPmax-min 34.37±11.59 28.47±8.56 t=2.787 0.006
? DBPSD 8.11±2.26 6.74±1.83 t=3.119 0.002
? DBPCV 10.48±3.25 8.40±2.42 t=0.146 0.001
表2 早期神经系统功能恶化的Logistics回归分析
1
Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke:implications for public education and organisation of services [J]. BMJ, 2004, 328 (7435): 326.
2
Yaghi S, Rostanski SK, Boehme AK, et al. Imaging parameters and recurrent cerebrovascular events in patients with minor stroke or transient ischemic attack [J]. JAMA Neurol, 2016, 73(5):572-578.
3
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack [J]. N Engl J Med, 2013, 369: 11-19.
4
王伊龙, 赵性泉, 刘新峰, 等. 高危非致残性缺血性脑血管事件诊疗指南 [J]. 中国卒中杂志, 2016, 11(6): 481-491.
5
Chen W, Pan Y, Jing J, et al. Recurrent stroke in minor ischemic stroke or transient ischemic attack with metabolic syndrome and/or diabetes mellitus [J]. J Am Heart Assoc, 2017, 6(6): e005446.
6
Ferrari J, Knoflach M, Kiechl S, et al. Early clinical worsening in patients with tia or minor stroke: the austrian stroke unit registry [J]. Neurology, 2010, 74(2):136-141.
7
Kim JT, Kim HJ, Yoo SH, et al. MRI findings may predict early neurologic deterioration in acute minor stroke or transient ischemic attack due to intracranial atherosclerosis [J]. Eur Neurol, 2010, 64(2): 95-100.
8
Li J, Zhao X, Meng X, et al. High-sensitive C-reactive protein predicts recurrent stroke and poor functional outcome: subanalysis of the clopidogrel in high-risk patients with acute nondisabling cerebrovascular events trial [J]. Stroke, 2016, 47(8): 2025-2030.
9
Stead LG, Gilmore RM, Vedula KC, et al. Impact of acute blood pressure variability on ischemic stroke outcome [J]. Neurology, 2006, 66(12): 1878-1881.
10
Delgado-Mederos R, Ribo M, Rovira A, et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke [J]. Neurology, 2008, 71(8): 552-558.
11
段作伟, 符长标, 唐铁钰, 等. 血压变异性与急性缺血性卒中患者早期神经功能恶化的相关性 [J]. 国际脑血管病杂志, 2017, 25(7) : 621-625.
12
中华医学会神经病学分会急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2014 [J]. 中华神经科杂志, 2014, 48(4): 246-257.
13
Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis [J]. AJNR Am J Neuroradiol, 2000, 21(4): 643-646.
14
Brott TG, Halperin JL, Abbara S, et al. 2011 ASA /ACCF /AHA/ AANN /AANS /ACR /ASNR /CNS /SAIP /SCAI /SIR /SNIS /SVM /SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary [J]. J Neurointerv Surg, 2011, 3(2): 100-130.
15
Kim JT, Yoon GJ, Park MS, et al. Lesion patterns of small deep infarcts have difierent clinical and imaging characteristics [J]. Eur Neurol, 2010, 63(6): 343-349.
16
Zawadzki MJ, Small AK, Gerin W. Ambulatory blood pressure variability: a conceptual review [J]. Blood Press Monit, 2017, 22(2): 53-58.
17
Manning LS, Rothwell PM, Potter JF, et al. Prognostic significance of short-term blood pressure variability in acute stroke: systematic review [J]. Stroke, 2015, 46 (9): 2482-2490.
18
Yi X, Zhou Q, Sui G, et al. Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation [J]. Brain Behav, 2019, 9(6): e01291.
19
Yi X, Zhou Q, Wang C, et al. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles [J]. J Neurol, 2018, 265(10): 2396-2403.
20
赵芳芳, 高浩源, 高利, 等. 颈动脉重度狭窄致急性脑梗死血压与预后研究 [J/CD]. 中华临床医师杂志(电子版), 2017, 11(2): 193-197.
21
Takahashi Y, Yamashita T, Morihara R, et al. Different characteristics of anterior and posterior branch atheromatous diseases with or without early neurologic deterioration [J]. J Stroke Cerebrovasc Dis, 2017, 26(6): 1314-1320.
22
Lacolley P, Bezie Y, Girerd X, et al. Aortic distensibility and structural changes in sinoaortic-denervated rats [J]. Hypertension, 1995, 26(2): 337-340.
23
Asdaghi N, Hill MD, Coulter JI, et al. Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study [J]. Stroke, 2013, 44(9): 2486-2492.
24
Chang JY, Jeon SB, Lee JH, et al. The Relationship between blood pressure variability, recanalization degree, and clinical outcome in large vessel occlusive stroke after an intra-arterial thrombectomy [J]. Cerebrovasc Dis, 2018, 46(5-6): 279-286.
25
Chappell DC, Varner SE, Nerem RM, et al. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium [J]. Circ Res, 1998, 82(5): 532-539.
26
Yi X, Zhou Q, Wang C, Lin J, et al. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles [J]. J Neurol, 2018, 265(10): 2396-2403.
27
Liu L, Dowlatshahi D. Dual Antiplatelet therapy for minor stroke and high-risk transient ischemic attack [J]. Stroke, 2018, 49(9): 2278-2279.
28
Kang J, Kim N, Park TH, et al. Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study [J]. BMC Neurol, 2015, 15: 122.
[1] 丁亚芳, 惠品晶, 郭周颖, 杨甲, 张李均, 胡春洪, 方琪. 评估椎动脉颅内段狭窄性病变部位的临床意义[J]. 中华医学超声杂志(电子版), 2017, 14(07): 487-493.
[2] 许秀兰, 朱建建. 血压变异性与伴H型高血压的急性脑梗死患者预后不良的临床关系分析[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 199-204.
[3] 曾书燚, 梁祥文, 林智海, 黎艺毅, 凌政, 王正东. 24小时尿蛋白、血压变异性与原发性高血压患者发生睡眠障碍的关系[J]. 中华临床医师杂志(电子版), 2023, 17(01): 48-53.
[4] 逯蕊, 赵丽丽, 韩元福, 李俊. 缺血性脑卒中患者血压变异性与预后相关性的研究进展[J]. 中华诊断学电子杂志, 2016, 04(02): 136-138.
[5] 王俊俊, 李雅国, 刘小利. 后循环短暂性脑缺血发作患者临床特征及脑卒中危险因素分析[J]. 中华老年病研究电子杂志, 2015, 02(01): 32-34,41.
[6] 姚富远, 陈芳兰, 邓哲. 非溶栓急性缺血性卒中患者早期神经功能恶化的影响因素分析[J]. 中华卫生应急电子杂志, 2022, 08(04): 193-198.
[7] 战晶晶, 彭斌. 血压变异性与脑白质高信号的研究进展[J]. 中华脑血管病杂志(电子版), 2021, 15(04): 258-262.
[8] 钟介石, 刘松, 朱榆红, 贾文姬, 王颖, 张婕, 韩剑虹. 尿激酶溶栓后出血及早期神经功能恶化危险因素的多中心研究[J]. 中华脑血管病杂志(电子版), 2021, 15(03): 163-169.
[9] 张小峰, 徐文灯, 武剑. 急性缺血性脑卒中患者脑白质病变与血压变异性的相关性[J]. 中华脑血管病杂志(电子版), 2021, 15(03): 153-156.
[10] 郑晶, 左靖. 阿替普酶联合丁苯酞对急性缺血性脑卒中患者静脉溶栓后早期神经功能恶化影响的研究[J]. 中华脑血管病杂志(电子版), 2020, 14(05): 281-285.
阅读次数
全文


摘要